AMH Equity’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-3,500
Closed -$293K – 36
2021
Q4
$293K Buy
+3,500
New +$393K 0.41% 22

Other funds holding CTSO

AMH Equity's CTSO Position: Q4 2024 in Review

AMH Equity sold out of Cytosorbents (CTSO) in Q4 2024, closing a stake of 4,140 shares — an estimated $124K sold.

AMH Equity first reported a position in CTSO in Q3 2024 and held it in 1 quarter. The position peaked at $124K in Q3 2024. 50 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

  • AMH Equity reported no remaining Cytosorbents position as of Q4 2024 after selling out during the quarter.
  • AMH Equity sold 4,140 Cytosorbents shares in Q4 2024, an estimated $124K.
  • AMH Equity first reported a position in Cytosorbents in Q3 2024 and held it in 1 quarter.
  • AMH Equity's Cytosorbents position peaked at $124K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Cytosorbents as of Q4 2024.

Based on AMH Equity's 13F filing for Q4 2024, filed 5 Feb 2025.